294 related articles for article (PubMed ID: 26490686)
21. Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.
Elbaz EM; Amin HAA; Kamel AS; Ibrahim SM; Helmy HS
Inflammopharmacology; 2020 Oct; 28(5):1407-1420. PubMed ID: 32785828
[TBL] [Abstract][Full Text] [Related]
22. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
23. Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats.
Shabani E; Kalantari H; Kalantar M; Goudarzi M; Mansouri E; Kalantar H
BMC Complement Med Ther; 2021 Dec; 21(1):301. PubMed ID: 34930229
[TBL] [Abstract][Full Text] [Related]
24. Flaxseed suppressed prostatic epithelial proliferation in a rat model of benign prostatic hyperplasia.
Said MM; Hassan NS; Schlicht MJ; Bosland MC
J Toxicol Environ Health A; 2015; 78(7):453-65. PubMed ID: 25785559
[TBL] [Abstract][Full Text] [Related]
25. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
[TBL] [Abstract][Full Text] [Related]
26. [Bushen Huoxue Fang promotes the apoptosis of epithelial cells in the prostatic ductal system of rats with benign prostatic hyperplasia].
Sun J; Li QF; Tian DZ; Jiang SB; Wu XD; Qiu SA; Ren XG; Li YB
Zhonghua Nan Ke Xue; 2014 Sep; 20(9):824-9. PubMed ID: 25306812
[TBL] [Abstract][Full Text] [Related]
27. Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats.
Lee MY; Shin IS; Seo CS; Lee NH; Ha HK; Son JK; Shin HK
Asian J Androl; 2012 Mar; 14(2):320-4. PubMed ID: 22231294
[TBL] [Abstract][Full Text] [Related]
28. Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Refaie MMM; Rifaai RA; Zenhom NM
Fundam Clin Pharmacol; 2018 Dec; 32(6):617-626. PubMed ID: 29862557
[TBL] [Abstract][Full Text] [Related]
29. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.
Sayed RH; Saad MA; El-Sahar AE
Toxicol Appl Pharmacol; 2016 Nov; 311():52-60. PubMed ID: 27687055
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of Kangshuailing Gao on benign prostatic hyperplasia in rats].
Li R; Jia DY; Li Z; Xu DR; Luo SY
Zhonghua Nan Ke Xue; 2018 Aug; 24(8):729-734. PubMed ID: 30173434
[TBL] [Abstract][Full Text] [Related]
31. Treatment of benign prostatic hyperplasia with Croton membranaceus in an experimental animal model.
Afriyie DK; Asare GA; Bugyei K; Adjei S; Lin JM; Peng J; Hong ZF
J Ethnopharmacol; 2014 Nov; 157():90-8. PubMed ID: 25256687
[TBL] [Abstract][Full Text] [Related]
32. Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats.
Adaramoye OA; Akanni OO; Abiola OJ; Owumi SE; Akinloye O; Olapade-Olaopa EO
Biomed Pharmacother; 2017 Nov; 95():1493-1503. PubMed ID: 28946212
[TBL] [Abstract][Full Text] [Related]
33. Effect of
Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH
Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335
[No Abstract] [Full Text] [Related]
34. Fatty Acids in Some Cooking Oils as Agents of Hormonal Manipulation in a Rat Model of Benign Prostate Cancer.
Oyelowo O; Okafor C; Ajibare A; Ayomide B; Dada K; Adelakun R; Ahmed B
Niger J Physiol Sci; 2019 Jun; 34(1):69-75. PubMed ID: 31449274
[TBL] [Abstract][Full Text] [Related]
35. Potential of telmisartan in the treatment of benign prostatic hyperplasia.
Ishola IO; Anunobi CC; Tijani KH; Afolayan O; Udokwu VU
Fundam Clin Pharmacol; 2017 Dec; 31(6):643-651. PubMed ID: 28727906
[TBL] [Abstract][Full Text] [Related]
36. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
[TBL] [Abstract][Full Text] [Related]
37. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
Wu SF; Sun HZ; Qi XD; Tu ZH
Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
[TBL] [Abstract][Full Text] [Related]
38. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
Yang X; Yuan L; Xiong C; Yin C; Ruan J
J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
[TBL] [Abstract][Full Text] [Related]
39. LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
Rick FG; Schally AV; Block NL; Halmos G; Perez R; Fernandez JB; Vidaurre I; Szalontay L
Prostate; 2011 May; 71(7):736-47. PubMed ID: 20945403
[TBL] [Abstract][Full Text] [Related]
40. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo.
Zhong X; Lin J; Zhou J; Xu W; Hong Z
Mol Med Rep; 2015 Aug; 12(2):1699-708. PubMed ID: 25825141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
